Literature DB >> 30377812

An overview of the ATOMS generations: port types, functionality and risk factors.

Sandra Mühlstädt1, Alexander Friedl2, Roman Zachoval3, Nasreldin Mohammed4, André Schumann4, Gerit Theil4, Paolo Fornara4.   

Abstract

BACKGROUND: We report the multicentre comparison of the different port types of the adjustable transobturator male incontinence system (ATOMS, A.M.I., Austria).
METHODS: Between 10/09 and 10/16, 383 patients received an ATOMS. Of these, 63% received the inguinal port (IP, 2009-2013), 23% the intraoperative manually connectable scrotal port (SP, 2013-2015), and 14% the pre-connected fully silicone-covered scrotal port (SSP, 2014-2016). During the follow-up period, continence parameters, pain and quality of life ratings and postoperative port-associated complications were evaluated and compared. Statistical analysis was performed with GraphPad Prism 7®, p < 0.05 considered as significant.
RESULTS: Regarding preoperative parameters (BMI, ASA score, previous radiotherapy/incontinence surgery, and preoperative 24-h pad count/24-h pad test), no significant differences were found. Regarding perioperative parameters, the mean operative time was significantly shorter for the SP and SSP (IP vs. SP p < 0.0001, IP vs. SSP p = 0.0048, SP vs. SSP p = 0.697). Comparison of the postoperative 24-h pad count, 24-h pad test and uroflowmetry data revealed no significant differences. However, the postoperative ICIQ-SF score was significantly better for the SSP (p = 0.0232) than the SP. A significant difference was also observed in postoperative port-associated complications. According to the Clavien-Dindo classification, we identified one grade I and 29 grade IIIb complications for the IP, 1 grade I and 6 grade IIIb complications for the SP, but only 2 grade IIIb complications for the SSP (IP vs. SP p = 0.0231, IP vs. SSP p = 0.0189 and SP vs. SSP p = 0.0453).
CONCLUSION: The SSP shows fewer complications while retaining comparable efficacy.

Entities:  

Keywords:  ATOMS; Artificial implants; Functionality; Male stress urinary incontinence; Port types

Mesh:

Year:  2018        PMID: 30377812     DOI: 10.1007/s00345-018-2548-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  3 in total

1.  Prostate-specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction With the In-bore 3-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy After Negative 12-Core Biopsy.

Authors:  Alexander Friedl; Kathrin Stangl; Wilhelm Bauer; Danijel Kivaranovic; Jenifer Schneeweiss; Martin Susani; Stephan Hruby; Lukas Lusuardi; Fritz Lomoschitz; Edith Eisenhuber-Stadler; Wolfgang Schima; Clemens Brössner
Journal:  Urology       Date:  2017-08-24       Impact factor: 2.649

2.  Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review.

Authors:  Dragan Ilic; Sue M Evans; Christie Ann Allan; Jae Hung Jung; Declan Murphy; Mark Frydenberg
Journal:  BJU Int       Date:  2017-11-17       Impact factor: 5.588

3.  Exploring pathways towards improving patient experience of robot-assisted radical prostatectomy (RARP): assessing patient satisfaction and attitudes.

Authors:  Bradley R Reynolds; Caroline Bulsara; Nik Zeps; Jim Codde; Nathan Lawrentschuk; Damien Bolton; Justin Vivian
Journal:  BJU Int       Date:  2018-05       Impact factor: 5.588

  3 in total
  2 in total

1.  Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study.

Authors:  Javier C Angulo; Ignacio Arance; Antonio Ojea; Manuel Carballo; Andrés Rodríguez; Javier Pereira; Miguel Rebassa; Antoine Teyrouz; Gregorio Escribano; Fernando Teba; Blanca Madurga; Francisco E Martins; Francisco Cruz
Journal:  World J Urol       Date:  2019-01-16       Impact factor: 4.226

2.  De novo OAB After ATOMS: An Underestimated Problem or a Rare Side Effect?

Authors:  Sandra Schönburg; Wilhelm Bauer; Nasreldin Mohammed; Clemens Brössner; Paolo Fornara
Journal:  Front Surg       Date:  2019-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.